A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-03-26) →
What happened
Polaris AI Pharma disclosed convertible bonds to raise US$6.73M, about 13.6% of its market value.
For context, this raise equals about 13.6% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$6.73M |
| vs. market value | 13.6% |
| Filed | 2026-03-18, Material event report (convertible bonds) |
| Source | DART rcept 20260318001235 → open original filing |
Versions of this filing
- 2026-03-18Original (this page)
- 2026-03-26Amendment 1
Source: DART. Information only, not investment advice.